Generate a tailored SOP for Dr. Kim Theilgaard Mønch. Improve your application with a focused, well-structured draft.
Kim Theilgaard-Mønch is an Associate Professor at the University of Copenhagen, specializing in hematology with a focus on Acute Myeloid Leukemia (AML) research. He obtained his MD degree from the University of Heidelberg and furthered his studies with a DMSc at Rigshospitalet, University of Copenhagen. His primary research interests include therapeutic targeting of leukemic stem cells, the biology of hematopoietic stem cells, and conducting clinical trials to improve outcomes for AML patients. He leads a research group within the Finsen Laboratory and is involved in collaborative efforts with several Nordic AML centers. His work emphasizes the identification of novel drug combinations and applications of advanced genomic techniques to refine treatment strategies for patients with therapy-resistant minimal residual disease. He has held several clinical roles throughout his career, including a Senior Consultant position at Copenhagen University Hospital - Rigshospitalet since 2018.
Finsen Laboratory, Rigshospitalet • Copenhagen, Denmark
Leading research on Acute Myeloid Leukemia and therapeutic targeting initiatives.
Copenhagen University Hospital - Rigshospitalet • Copenhagen, Denmark
Providing clinical expertise in hematology while leading research efforts.
Skåne University Hospital • Lund, Sweden
Worked as a clinician in the Department of Hematology.
Laboratory for Gene Therapy Research, Rigshospitalet • Copenhagen, Denmark
Conducted research in gene therapy.
Focuses on clinical, social, and cognitive psychology.